Title : Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway.

Pub. Date : 2020

PMID : 33061461






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKbeta/NF-kappaB Signaling Pathway. Emodin nuclear factor kappa B subunit 1 Homo sapiens
2 Emodin significantly reduced NF-kappaB activity and emodin significantly promoted P-gp fluorescence intensity from Rhodamine 123 efflux assay. Emodin nuclear factor kappa B subunit 1 Homo sapiens
3 Conclusion: Emodin inhibits the expression of IKKbeta, thereby inhibiting the expression and activity of downstream NF-kappaB, and inhibits P-gp function at the same time, ultimately achieving the purpose of reversing the drug-resistance of pancreatic cancer cell lines. Emodin nuclear factor kappa B subunit 1 Homo sapiens